바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.59 No.4
Citation Share

Effect of Tuberculin Skin Test on Ex-vivo Interferon-gamma Assay for Latent Tuberculosis Infection

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2005, v.59 no.4, pp.406-412










& (2005). Effect of Tuberculin Skin Test on Ex-vivo Interferon-gamma Assay for Latent Tuberculosis Infection. Tuberculosis & Respiratory Diseases, 59(4), 406-412.
  • Downloaded
  • Viewed
PDF Download

Abstract

Background : Recently, two commercialized whole-blood assays, QuantiFERON-TB Gold (QFT) and T SPOT-TB (SPOT), which measure the IFN-γ released in the whole blood after being incubation with mycobacterial antigens, were approved for the diagnosis of a latent tuberculosis infection (LTBI). However, there is data on whether or not the previously used PPD skin tests (TST) have any influence on the diagnostic ability of these ex-vivo IFN-γ assays. Methods : Forty-six 15 year-old students who did not appear to be infected with Mycobacterium tuberculosis were enrolled in this study. The peripheral blood was collected and used for two IFN-γ assays. The IFN-γ assays and TST were performed at the baseline (1st). The TST was repeated two months later (2nd), and the IFN-γ assays were repeated two (2nd) and four months (3rd) later only in those subjects who had negative results at the baseline in both the IFN-γ assays and TST. An induration size > 10 mm was considered to be positive in the TST. Results : The mean TST value was 3.1 ± 5.4 mm (range: 0-20). Of the 46 subjects examined, 13 subjects (28.3%) showed positive results in the two-step TST. Nine (19.6%) were SPOT-positive and only one (2.2%) was QFT-positive. The 2nd and 3rd QFT were carried out in 23 and 25 all-negative subjects, respectively, and all showed negative results. The 2nd SPOT was performed in 23 subjects and only one (4.3%) showed a weak-positive result. Conclusion : Even though there were some discrepancies in the results of the two ex-vivo IFN-γ assays, it appears that their results were not influenced by a previous TST carried out in two or four months earlier. (Tuberc Respir Dis 2005; 59: 406-412)

keywords
Latent tuberculosis infection, Interferon-gamma assay, Tuberculin skin test, Purified Protein Derivative, Latent tuberculosis infection, Interferon-gamma assay, Tuberculin skin test, Purified Protein Derivative

Reference

1.

(2004) Priorities for the treatment of latent tuberculosis infection in the United States,

2.

(2002) Clinical practice:latent tuberculosis infection,

3.

(1995) National survey of mycobacterial diseases other than tuberculosis in Korea,

4.

(1993) Korean Academy of Tuberculosis and Respiratory Disease,

5.

(2001) Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi,

6.

(1985) Tuberculin test:variability with the Mantoux procedure,

7.

(1996) Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG,

8.

(2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis:a systematic review,

9.

(2004) The effect of tuberculin skin testing on viral load and anti-mycobacterial immune responses in HIV-1-infected Ugandan adults,

10.

(2003) Comparison of tuberculosis tests finding truth or confirming prejudice,

11.

(2002) Evaluation of a whole-blood interferon-gamma release assay for the detection of Mycobacterium tuberculosis infection in 2 study populations,

12.

(1999) Evaluation of the tuberculin gamma interferon assay:potential to replace the Mantoux skin test,

13.

(1998) Development of a human gamma interferon enzyme immunoassay and comparison with tuberculin skin testing for detection of Mycobacterium tuberculosis infection,

14.

(1995) Ministry of Health & Welfare KNTA Report on the 7th tuberculosis prevalence survey in Korea Ministry of Health & Welfare,

15.

(2002) A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements,

16.

(1997) Evaluation of the interferon-gamma ELISPOT-assay for quantification of peptide specific T lymphocytes from peripheral blood,

17.

(2002) The ELISPOT assay:an easily transferable method for measuring cellular responses and identifying T cell epitopes,

18.

(2001) Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians,

19.

(2003) Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis,

20.

(1999) In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene,

21.

(2004) Specific detection of tuberculosis infection:an interferon-gamma-based assay using new antigens,

Tuberculosis & Respiratory Diseases

e-Submission OA Policy